KRAS and BRAF genotyping of synchronous colorectal carcinomas
Targeted sequencing reveals distinct pathogenic variants in Chinese patients with lung adenocarcinoma brain metastases
Eprobe-mediated screening system for somatic mutations in the KRAS locus
3F8 monoclonal antibody treatment of patients with stage 4 neuroblastoma: a phase II study.
High concordance rate of KRAS/BRAF mutations and MSI-H between primary colorectal cancer and corresponding metastases